Home » Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

This post was originally published on this site.

Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its US FDA approval.